NO964517D0 - Anvendelse av et salt for fremstilling av et kosmetisk, dermatologisk eller farmasöytisk preparat, preparatet som sådan samt fremgangsmåte for kosmetisk behandling - Google Patents

Anvendelse av et salt for fremstilling av et kosmetisk, dermatologisk eller farmasöytisk preparat, preparatet som sådan samt fremgangsmåte for kosmetisk behandling

Info

Publication number
NO964517D0
NO964517D0 NO964517A NO964517A NO964517D0 NO 964517 D0 NO964517 D0 NO 964517D0 NO 964517 A NO964517 A NO 964517A NO 964517 A NO964517 A NO 964517A NO 964517 D0 NO964517 D0 NO 964517D0
Authority
NO
Norway
Prior art keywords
preparation
cosmetic
salt
dermatological
pharmaceutical composition
Prior art date
Application number
NO964517A
Other languages
English (en)
Other versions
NO964517L (no
Inventor
Olivier De Lacharriere
Lionel Breton
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of NO964517D0 publication Critical patent/NO964517D0/no
Publication of NO964517L publication Critical patent/NO964517L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO964517A 1995-10-26 1996-10-24 Anvendelse av et salt for fremstilling av et kosmetisk, dermatologisk eller farmasöytisk preparat, preparatet som sådan samt fremgangsmåte for kosmetisk behandling NO964517L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512658A FR2740335B1 (fr) 1995-10-26 1995-10-26 Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p

Publications (2)

Publication Number Publication Date
NO964517D0 true NO964517D0 (no) 1996-10-24
NO964517L NO964517L (no) 1997-04-28

Family

ID=9483959

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964517A NO964517L (no) 1995-10-26 1996-10-24 Anvendelse av et salt for fremstilling av et kosmetisk, dermatologisk eller farmasöytisk preparat, preparatet som sådan samt fremgangsmåte for kosmetisk behandling

Country Status (9)

Country Link
US (1) US5900257A (no)
EP (1) EP0770392B1 (no)
JP (1) JP3112844B2 (no)
AT (1) ATE300948T1 (no)
CA (1) CA2188892C (no)
DE (1) DE69635010T2 (no)
ES (1) ES2246493T3 (no)
FR (1) FR2740335B1 (no)
NO (1) NO964517L (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
MX9710479A (es) * 1995-09-07 1998-03-31 Oreal Extracto de iridaceas y composiciones que la contienen.
AT405017B (de) * 1997-10-06 1999-04-26 Jakoby Marie Luise Mittel zur stimulation der körpereigenen abwehr
NZ501211A (en) * 1999-01-29 2001-10-26 Pfizer Prod Inc Pharmaceutical composition comprising macrolide antibiotic like erythromycin and a Substance P antagonist, and method for treating cancer, bacterial and protozoal infection in non-humans
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
US6706272B2 (en) 2000-03-08 2004-03-16 Shinto Fine Co., Ltd. Method for denaturing allergens
FR2809006B1 (fr) * 2000-05-18 2002-08-02 Oreal Utilisation du manganese dans des compositions destinees a combattre la paleur de la peau
FR2809005B1 (fr) * 2000-05-18 2002-12-27 Oreal Utilisation du manganese dans le traitement des rides
AU2001282988B2 (en) * 2000-07-26 2006-01-05 Atopic Pty Ltd Methods for treating atopic disorders
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
US20030059450A1 (en) 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
WO2003048421A1 (en) * 2001-12-05 2003-06-12 Micromed Laboratories, Inc. Method and apparatus for producing negative and positive oxidative reductive potential (orp) water
US7081247B2 (en) * 2002-05-20 2006-07-25 Nidaria Technology Ltd. Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
AU2002365172A1 (en) * 2002-12-09 2004-06-30 Evgeny Nikolaevich Ananiev Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects
US6923952B2 (en) * 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US6902723B2 (en) * 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US9168318B2 (en) * 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
JP5528657B2 (ja) * 2003-12-30 2014-06-25 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液並びにその製造方法および使用方法
US20050139808A1 (en) * 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US20080194487A1 (en) * 2005-01-12 2008-08-14 Witten Mark L Treatment of Skin Diseases
EP1863502B1 (en) * 2005-03-23 2018-09-12 Sonoma Pharmaceuticals, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
BRPI0610901B1 (pt) 2005-05-02 2019-04-16 Oculus Innovative Sciences, Inc. Uso de uma solução aquosa de potencial oxi-redutivo (orp).
JP5449780B2 (ja) * 2006-01-20 2014-03-19 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた炎症及び過敏症の治療又は予防方法
JP2010501551A (ja) * 2006-08-25 2010-01-21 テウン イーエルエス インコーポレイテッド 毛髪改善のための希土類元素の用途
KR100818175B1 (ko) 2007-12-12 2008-04-02 주식회사 태웅이엘에스 모발처리용 조성물
JP2010200971A (ja) * 2009-03-03 2010-09-16 Hoyu Co Ltd 異常脱毛予測／推定方法、異常脱毛予防／防止方法及び異常脱毛防止剤評価方法
BRPI1011886B1 (pt) 2009-06-15 2022-05-03 Invekra, S.A.P.I De C.V Solução antimicrobiana de baixo ph
DE102012110009A1 (de) * 2012-10-19 2014-04-24 Thomas Gniech Mittel zur Linderung oder gegen Migräneschmerzen
EP4450058A2 (fr) * 2012-12-27 2024-10-23 Jean-Claude Epiphani Procédé de fabrication d'une émulsion aqueuse d'une substance active huileuse pour application cosmétique, alimentaire ou pharmaceutique
US9498612B2 (en) 2013-03-14 2016-11-22 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
FR3031677B1 (fr) * 2015-01-16 2019-06-07 L'oreal Composition cosmetique pour administration par voie topique pour renforcer la barriere cutanee.
WO2018212349A1 (ja) * 2017-05-19 2018-11-22 サントリーホールディングス株式会社 ディスペンスヘッド及びそれを利用した飲料注出路の洗浄方法
WO2020091699A1 (en) 2018-10-31 2020-05-07 Yeditepe Universitesi Use of nano-sized lanthanide borate (dysprosium borate and erbium borate) compounds for wound healing purposes and production method thereof

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE297062C (no) *
GB997975A (en) * 1964-01-31 1965-07-14 Aristotelis Papageorgiou Lambo Pharmaceutical compositions containing a cresol or a mixture of cresols
GB1072355A (en) * 1964-06-17 1967-06-14 Michael Collin Antiseptic and anti-pruretic solution containing camphor
US3519711A (en) * 1967-09-01 1970-07-07 Robert E Svigals Composition and method of treating pruritic conditions of the skin
IE35991B1 (en) * 1971-01-22 1976-07-21 Comprehensive Pharmaceuticals Improvements in or relating to the treatment of diseases of the skin and mucosa
LU65373A1 (no) * 1972-05-17 1973-11-23
US3888976A (en) * 1972-09-21 1975-06-10 William P Mlkvy Zinc and strontium ion containing effervescent mouthwash tablet
US3772431A (en) * 1972-09-21 1973-11-13 W Mlkvy Effervescent mouthwash tablet
DE2715711A1 (de) * 1977-04-07 1978-10-19 Robugen Gmbh Topisch anwendbares arzneimittel zur behandlung von viruserkrankungen der haut und der schleimhaut
DE3030215A1 (de) * 1980-08-09 1982-03-18 Bergwerksverband Gmbh, 4300 Essen Wirbelbett-feuerung
US4477439A (en) * 1981-04-13 1984-10-16 Walter J. Monacelli Treatment of irritated and excoriated areas around the stoma of ostomy patients
WO1983001252A1 (en) * 1981-10-09 1983-04-14 Hakanson, Rolf A drug based on a substance p antagonist
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
DE3338957A1 (de) * 1983-10-27 1985-05-15 Keyhan Dipl.-Ing. 6908 Wiesloch Ghawami Enthaarungsmittel
DE3443985A1 (de) * 1984-12-01 1986-06-05 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Arzneimittelzubereitungen gegen mykotische und bakterielle infektionen mit einem gehalt an wirkstoffen, welche zink in ionisierter form freisetzen
IT1214611B (it) * 1985-05-22 1990-01-18 Schiena Ricerche Composti per uso cosmetico dermatologico e relative composizioni.
US4837026A (en) * 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
DE3584837D1 (de) * 1985-10-08 1992-01-16 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
FR2599967B1 (fr) * 1986-06-16 1989-03-31 Bfb Etudes Rech Experimentale Utilisation de sel de zinc et de la vitamine b6 pour enrayer les processus alopeciques et/ou seborrheiques.
US4986981A (en) * 1986-07-07 1991-01-22 Den Mat Corporation Toothpaste having low abrasion
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
SE8701372L (sv) * 1987-04-02 1988-10-03 Boliden Ab Foerfarande och medel foer konservering av hoe
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
DE3929411A1 (de) * 1988-09-22 1990-03-29 Siegfried Natterer Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
CA2014201A1 (en) * 1989-04-26 1990-10-26 Albemarle Corporation Solid non-hygroscopic trialkylamine oxides
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations
SU1679008A1 (ru) * 1989-07-26 1991-09-23 Производственно Промышленное Объединение "Железобетон" Арматурный элемент дл дисперсного армировани бетона
US5202130A (en) * 1989-08-31 1993-04-13 The Johns Hopkins University Suppression of eczematous dermatitis by calcium transport inhibition
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
ATE94399T1 (de) * 1990-01-29 1993-10-15 Wogepharm Gmbh Verfahren zur herstellung von mitteln zur therapie von hauterkrankungen.
EP0451300B1 (fr) * 1990-04-10 1994-10-26 Romuald Dr. Kowalski Composition contenant une dispersion colloidale de sulfate de baryum
US5401730A (en) * 1990-07-06 1995-03-28 The Hope Heart Institute Method for reducing platelet aggregation
DE69208088T2 (de) * 1991-07-05 1996-11-14 Merck Sharp & Dohme Aromatische verbindungen, diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische anwendung
JPH06509090A (ja) * 1991-07-10 1994-10-13 メルク　シヤープ　エンド　ドーム　リミテツド 芳香族化合物、それらを含む組成物、及び治療におけるそれらの使用
RU2038072C1 (ru) * 1991-11-01 1995-06-27 Государственный российский научно-исследовательский институт органической химии и технологии Крем для защиты кожи от химических веществ и способ его получения
GB9201179D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
ATE341316T1 (de) * 1992-07-20 2006-10-15 Massachusetts Inst Technology Kontrolle der wundvernarbung mit calmodulin- inhibitoren oder protein-kinase-c-inhibitoren
DE9211006U1 (de) * 1992-08-17 1993-12-16 Kao Corporation GmbH, 40472 Düsseldorf Mittel zur Haarbehandlung
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
CA2148256A1 (en) * 1992-10-29 1994-05-11 Ralph M. Hart Compositions and methods suitable for therapeutic and pharmaceutical uses
DK0801554T3 (da) * 1994-12-21 2003-08-04 Cosmederm Technologies Formuleringer og fremgangsmåder til reduktion af hudirritation
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
WO1996019182A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation

Also Published As

Publication number Publication date
EP0770392B1 (fr) 2005-08-03
FR2740335A1 (fr) 1997-04-30
US5900257A (en) 1999-05-04
DE69635010T2 (de) 2006-04-20
JPH09165341A (ja) 1997-06-24
CA2188892C (fr) 2008-06-17
DE69635010D1 (de) 2005-09-08
ATE300948T1 (de) 2005-08-15
CA2188892A1 (fr) 1998-04-25
EP0770392A2 (fr) 1997-05-02
FR2740335B1 (fr) 1997-12-19
NO964517L (no) 1997-04-28
EP0770392A3 (fr) 1997-05-07
ES2246493T3 (es) 2006-02-16
JP3112844B2 (ja) 2000-11-27

Similar Documents

Publication Publication Date Title
NO964517D0 (no) Anvendelse av et salt for fremstilling av et kosmetisk, dermatologisk eller farmasöytisk preparat, preparatet som sådan samt fremgangsmåte for kosmetisk behandling
NO964515L (no) Anvendelse av et salt for fremstilling av et farmasöytisk eller dermatologisk preparat
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
MX4392A (es) Procedimiento para la preparacion de un producto de endurecimiento basado en compuestos olefinicamente insaturados y compuestos activos en el hidrogeno asi como el empleo de este sistema para lacas de dos componentes.
BR8905983A (pt) Conjunto descartavel de recipiente e bocal pulverizador,e recipiente descartavel para liquido
DE59404719D1 (de) Verfahren zur Herstellung von Diarylcarbonaten
AR023044A1 (es) Composicion farmaceutica soluble en agua en un complejo no ionico y uso del mismo
DE59309513D1 (de) Verfahren zur Herstellung von Polysuccinimid, Polyasparaginsäure und ihrer Salze
AU2898297A (en) Use of substance p antagonists for treating social phobia
FR2688136B1 (fr) Composition cosmetique contenant des pigments melaniques en association avec certains tocopherols, et procede de protection de la peau, des cheveux, des muqueuses et des compositions cosmetiques.
IT1289581B1 (it) Miscela,composizione per la protezione delle piante contenente la miscela e suo impiego
ID21545A (id) Turunan biphenil yang tersubstitusi dengan radikal aromatik atau heteroaromatik, serta komposisi farmasi dan kosmetik yang mengandungnya
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
ID16846A (id) Metoda untuk mengasam awetkan permukaan metalik larutan pengasamawetannya, dan proses untuk regenerasi larutan pengasam awetan yang digunakan
DE69420827D1 (de) Verfahren zur Herstellung von wässrigen Emulsionen zur Umhüllung von festen pharmazeutischen Zusammensetzungen
DE59003553D1 (de) Verfahren zur Herstellung von mindestens eine aromatische Estergruppe enthaltenden Kohlensäurediestern.
MX9206025A (es) Agente preventivo de costra de polimero, recipiente de polimerizacion efectivo en la prevencion de deposicion de costra de polimero y procedimiento para producir polimero usando dicho recipiente
DE68900485D1 (de) Derivate von phenoxyalkylcarbonsauere und verfahren zu ihrer herstellung.
DE3683425D1 (de) Polyesterkarbonat des imidgruppierungen enthaelt, und verfahren fuer dessen herstellung.
DE69823275T2 (de) Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Arzneimitteln
CA2199624A1 (en) Polymerizable aromatic carboxylic acids and carboxyanhydrides with cyclic carbonate groups, as well as preparations containing these compounds
DE3163007D1 (en) Agents for the treatment, the healing and the protection of trees' inflictions
ATA100294A (de) Mittel zur abwehr landbewohnender schnecken mit hilfe von pflanzeninhaltsstoffen
DE3665001D1 (en) Process for the protection of keratin-containing material against attack by keratin pests, and esters
IT1259308B (it) Procedimento per il trattamento e il confezionamento per la vendita difrutta, in particolare di ananas